Hong Kong-listed biopharmaceutical stocks are active, with Huahao Zhongtian Pharmaceutical soaring more than 40%.

Hong Kong biopharmaceutical stocks are active, with Huahao Zhongtian Pharmaceuticals surging by over 40%, Maiwei Biotech rising by over 23%, Yinnuo Pharmaceuticals and Yiming Angke increasing by over 7%, Taige Pharmaceuticals and Corunbotai Biotechnology rising by over 4%, and WuXi AppTec gaining nearly 3%.